ArticleFrontiers in oncology2022
A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer.
Yuqin Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it